Sorafenib induces pigmentation via the regulation of ß-catenin signalling pathway in melanoma cells.

Kim, Kyung-Il; Jung, Kyung Eun; Shin, Young-Bin; Kim, Chang-Deok; Yoon, Tae-Jin

Kim, Kyung-Il; Jung, Kyung Eun; Shin, Young-Bin; Kim, Chang-Deok; Yoon, Tae-Jin.

Afiliação

Kim KI; Department of Dermatology, School of Medicine, Chungnam National University, Daejeon, Korea.
Jung KE; Department of Medical Science, School of Medicine, Chungnam National University, Daejeon, Korea.
Shin YB; Department of Dermatology and Institute of Health Sciences, School of Medicine, Gyeongsang National University & Hospital, Jinju, Korea.
Kim CD; Department of Dermatology, School of Medicine, Chungnam National University, Daejeon, Korea.
Yoon TJ; Department of Dermatology and Institute of Health Sciences, School of Medicine, Gyeongsang National University & Hospital, Jinju, Korea.

Exp Dermatol ; 31(1): 57-63, 2022 01.

Article em En | MEDLINE | ID: mdl-32391926

Assuntos

Antineoplásicos/farmacologia; Melanoma/patologia; Pigmentação/efeitos dos fármacos; Neoplasias Cutâneas/patologia; Sorafenibe/farmacologia; beta Catenina/metabolismo; Antineoplásicos/metabolismo; Linhagem Celular Tumoral; Humanos; Transdução de Sinais/efeitos dos fármacos; Sorafenibe/metabolismo

Palavras-chave

GSK3ß; pigmentation; sorafenib; ß-catenin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Pigmentação / Beta Catenina / Sorafenibe / Melanoma / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google